The global nucleotide market size was USD 403.1million in 2014. Globally, the rising application scope of nucleotide in various end-use industries such as pharmaceuticals, food & beverage additive, animal feed additive, and diagnostics research is likely to augment the growth. Rising consumer awareness related to the ill effects of savory ingredients the demand for nucleotide-based flavor enhancers is anticipated to drive demand.
Increasing application scope of the product in industries including pharmaceuticals particularly in the U.S. and Canada is expected to have a positive impact on industry growth. Globally rising demand from the livestock industry for animals and increased health concern of animals has raised the demand for food additives.
Growing and expanding the use of nucleotide in diagnostics research for determining and testing diseases including the presence of various viral infections or a certain type of cancer is expected to propel demand over the next few years. In addition, favorable government policies worldwide are expected to propel demand over the forecast period.
The growing use of nucleotide in nutraceutical products under conditions such as poor diet or stress will help in optimizing the function of the immune systems which is expected to propel growth. Furthermore, increasing pressure from various health and safety organizations regarding human safety is expected to promote demand over the next seven years.
Diagnostics research was the largest application segment, accounting for 42.6% of global volume in 2014. Growing and expanding the use of the product in diagnostics research for determining and testing diseases including the presence of various viral infections or a certain type of cancer is expected to propel demand over the next few years.
Food & beverage additive are expected to grow on account of rising demand for flavor enhancers particularly in Asia Pacific, Europe, and North America. In addition, versatile health benefits associated with nucleotide makes it suitable for its use in food & beverage and medical purpose is likely to propel growth over the forecast period.
Major processes in the industry include TaqMan allelic discrimination, Gene chips & microarrays and SNP by pyrosequencing. Among these key processes, TaqMan allelic discrimination dominated the global in the recent past, followed by SNP by pyrosequencing. TaqMan allelic discrimination process was valued over USD 230.8 million in 2014 and is expected to witness significant growth owing to growing demand from in diagnostic research.
Asia Pacific region is expected to witness considerable growth in TaqMan allelic discrimination technology owing to the prevalence of chronic diseases. SNP by pyrosequencing process is expected to witness brisk growth over the forecast owing to high demand from the end-use industries and various advantages such as it easy to read and share and it gives true sequence information.
North America was the largest nucleotide market, accounting for 31.4% of global volume in 2014. The region is expected to dominate the industry over the forecast period due to the growing interest of the consumer in nutritional food products. Also, increasing self-medication coupled with rising awareness regarding health safety is likely to propel demand over the forecast period.
Europe accounted for the second-largest market, accounting for 26.1% of the global market share in 2014 owing to large scale use of the chemical in the pharmaceutical sector over the past few years. Rising application scope in nutraceutical products as it helps raise the resistance to bacterial infections in human and animals are expected to fuel demand.
Key industry participants include CJ CheilJedang Corporation, Star Lake Bioscience Co., Inc, ThermoFisher Scientific Inc., Meihua Group, F. Hoffmann-La Roche Ltd, Biorigin, DSM Nutritional Products Ltd., Promega Corporation, Affymetrix Inc., Agilent Technologies Inc., Lallemand Inc., Nanjing BioTogether Co., Ltd., NuEra Nutrition and Ohly GmbH. The industry is integrated across various stages of the value chain particularly from nucleotide manufacturers to end-use industries. In addition, integration across numerous stages of the value chain results in continuous raw material supply as well as low manufacturing cost.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
Demand across the organic chemicals sector shall register a slump in growth albeit increasing demand for certain chemicals that find end applications in healthcare and food. Furthermore, China, a major supplier of chemicals to the world, registered a considerable decline in manufacturing in the first quarter of 2020, following the trajectory unfolded by COVID-19's escalation to a pandemic. This has led to an imbalance in supply-demand dynamics, forcing manufacturers and customers alike to renegotiate supply agreements. The report will account for Covid19 as a key market contributor.